Whereas mTORC1 inhibition reduces the survival of normal cells in hypoxia, it supports the emergence of tumour cells that are resistant to hypoxia because, in a situation of restoration of mTOR signalling, cancer cells become sensitive to hypoxia again [31, 63]. This evidence concerns the gene MTOR and cancer.